US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 6.130
  • -0.030-0.49%
Close Feb 14 16:00 ET
  • 6.250
  • +0.120+1.96%
Post 20:01 ET
340.90MMarket Cap-3.31P/E (TTM)

About Foghorn Therapeutics Company

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Company Profile

SymbolFHTX
Company NameFoghorn Therapeutics
Listing DateOct 23, 2020
Issue Price16.00
Founded2015
CEOMr. Adrian Gottschalk
MarketNASDAQ
Employees116
Fiscal Year Ends12-31
Address500 Technology Square,Suite 700
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-586-3100
Websitehttp://www.foghorntx.com

Company Executives

  • Name
  • Position
  • Salary
  • Adrian Gottschalk
  • Chief Executive Officer and Director
  • 2.50M
  • Dr. Steven F. Bellon, PhD
  • Chief Scientific Officer
  • 1.19M
  • Fanny Cavalie
  • Chief Strategy and Business Operations Officer
  • --
  • Michael J. LaCascia
  • Chief Legal Officer
  • --
  • Kristian F. Humer
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Carlos Costa
  • Chief People Officer
  • --
  • Dr. Alfonso Quintas-Cardama
  • Chief Medical Officer
  • 1.84M
  • Dr. Douglas G. Cole, M.D.
  • Chairman of the Board
  • 184.57K
  • B. Lynne Parshall, Esq.,J.D.
  • Independent Director
  • 157.65K
  • Dr. Thomas J. Lynch
  • Independent Director
  • 145.57K
  • Dr. Michael Mendelsohn, M.D.
  • Independent Director
  • 154.57K
  • Ian F. Smith
  • Independent Director
  • 141.57K
  • Dr. Scott Biller, PhD
  • Independent Director
  • 145.57K
  • Dr. Balkrishan Gill, PhD
  • Independent Director
  • 159.07K
  • Stephen J. DiPalma
  • Treasurer
  • --
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Argo Blockchain
ARBK
+5.33%
BTCS Inc
BTCS
+3.20%
Canaan
CAN
+2.29%
Bit Origin
BTOG
+1.90%
Bitfarms
BITF
+1.43%

Unlock the Full List